FURIN and cystic fibrosis: Further clinical development of a furin inhibitor for the treatment of chronic airways disease will, however, have to remain cognisant of the potential level of redundancy that may exist between furin and other PCs in the airways when determining the safety and efficacy of locally targeted furin inhibition in diseases such as CF.